The Vital Difference: Independent Community Pharmacies vs. Chain Pharmacies

The Vital Difference: Independent Community Pharmacies vs. Chain Pharmacies

Introduction In today’s fast-paced world, pharmacies play a vital role in granting people access to fundamental medicines and health services. There are two primary categories of pharmacies: independent community pharmacies and chain pharmacies. Despite serving as crucial healthcare facilities, they differ greatly in treating patients, offering customized services, and incorporating with the community. In this…

More
Imagine where your Clinical Trials can go…

Imagine where your Clinical Trials can go…

While RxE2 continues promoting the practice of pharmacy and community-based pharmacists in clinical trials in the United States, the European Association of Hospital Pharmacies (EAHP) is encouraging the involvement of hospital pharmacists in European clinical trials. RxE2 applauds the EAHP for taking a position on clinical trials and their recognition of the valuable contributions pharmacists…

More
Diversity in Clinical Trials

Diversity in Clinical Trials – How to stop talking about it and actually do it

Diversity in Clinical Trials – Background The Federal Drug Administration (FDA) issued non-compulsory guidance on clinical trial diversity to encourage diverse populations in clinical trials and improve the applicability of clinical trial results. The guidance recommends diverse clinical trial populations to better understand the safety and effectiveness of medical products across race, ethnicity, and gender.…

More

RxE2 Founder and CEO Gerald Finken on the Role and Value of Pharmacists in Clinical Research

Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. Surprisingly, their skill sets are rarely used in clinical trials. That’s why Founder and CEO Gerald Finken created RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, offering primary stakeholders their…

More

E2 Dispensing Webinar

Welcome to our E2 Dispensing Webinar series. Over the next few weeks, we will release 8 episodes, introducing the E2 dispensing methodology and ecosystem to all. These webinars are aimed at everyone involved in clinical research and clinical trials. We will go into RxE2’s innovative and disruptive way of simplifying decentralized clinical trials and more specifically introducing…

More

How to boost excellence and innovation in clinical supply chains

By: Gerald E. Finken Originally posted on Linkedin In November 2021, McKinsey & Company published an interesting article on how to boost excellence and innovation in clinical supply chains that are relevant to today’s industry practices. What I found most compelling was how a best-in-class clinical supply chain could change and adapt to accommodate decentralized clinical trials (DCTs)…

More

The Impact of Decentralized Clinical Trials on the Investigational Drug Supply Chain: Making Clinical Supplies Patient-Centric

By: Gerald E. Finken The introduction of decentralized clinical trials (“DCTs”) into clinical research has, in recent years, focused on the use of technology and telehealth to improve the clinical trial experience for patients. The proponents of the DCT model have heralded it, and rightly so, with improving study recruitment, providing better patient diversity, and…

More

Gerald Finken’s Big Idea That Might Change The Medical World

I want to make clinical trials available to everyone, everywhere by bringing the practice of pharmacy into clinical research. Believe it or not, this has never been done before. It will improve healthcare by giving people worldwide clear access to more lifesaving medicines and access to the medication experts — the pharmacist. In an interview…

More